Colabor Group Q2 2025 slides: revenue up 5.1%, profits plunge 44.9%

Colabor Group Inc. (TSX:GCL) shares tumbled 13.68% following its Q2 2025 earnings, which reported a significant profit decline and a sharp increase in leverage despite a 5.1% revenue rise to $169.5 million, largely driven by acquisitions. Adjusted EBITDA plummeted 44.9% to $5.4 million, resulting in a net loss of $2.3 million, while net debt more than doubled to $97.3 million, pushing the leverage ratio to 4.3x. This deterioration in profitability and balance sheet strength, attributed to margin compression and acquisition-related debt, has raised investor concerns about the sustainability of the company's growth strategy.

Analysis

Colabor Group's Q2 2025 results reveal a significant deterioration in financial health, where acquisition-driven revenue growth masks severe underlying weakness. While consolidated sales rose 5.1% to $169.5 million, fueled by the Alimplus and Tout-Prêt acquisitions, the company's profitability collapsed. Adjusted EBITDA fell 44.9% to $5.4 million, and the adjusted EBITDA margin contracted sharply to 3.2% from 6.0% in the prior year, a decline management attributes to the repricing of a key supply agreement. This operational decline resulted in a net loss of $2.3 million, reversing a $1.7 million profit from Q2 2024. Most concerning is the dramatic increase in financial risk; net debt more than doubled to $97.3 million, propelling the company's leverage ratio from 2.4x to a precarious 4.3x adjusted EBITDA. This second consecutive quarter of disappointing results, combined with a disclosed cybersecurity incident and the appointment of an interim CFO, paints a picture of a company whose growth strategy is currently value-destructive, eroding margins and jeopardizing balance sheet stability.

Key Decisions for Investors

• Investors should view the top-line growth with significant skepticism, as the sharp decline in profitability and a leverage ratio of 4.3x signal that the current acquisition strategy is not creating shareholder value.
• A defensive stance is warranted; consider reducing exposure or avoiding new positions until management demonstrates a clear path to restoring gross margins and deleveraging the balance sheet.
• Monitor progress on the Alimplus integration closely, as any failure to realize expected synergies will further strain cash flows and the company's ability to service its significantly higher debt load.
• Factor in heightened tail risk from the unquantified financial impact of the recent cybersecurity breach and the leadership uncertainty implied by an interim CFO appointment.